DENSULENT® Insulin Glargine Injectable Solution
Composition Each ml of injectable solution of DENSULENT® contains: Insulin glargine 3.64 mg (equivalent to 100 U). Excipients: m-cresol, Glycerin, Zinc Chloride, Sodium Hydroxide, Hydrochloric Acid, WFI q.s.p. 1 ml Indications DENSULENT® is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. Presentations 3 ml prefilled pens containing insulin glargine
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
